Knowledge About HPV and the HPV Vaccine: Observational Study on a Convenience Sample of Adolescents from Select Schools in Three Regions in Italy

被引：0

作者：

Brunelli, Laura ^{[1
,2
]}

Valent, Francesca ^{[3
]}

Comar, Manola ^{[4
,5
]}

Suligoi, Barbara ^{[6
]}

Salfa, Maria Cristina ^{[6
]}

Gianfrilli, Daniele ^{[7
]}

Sesti, Franz ^{[7
]}

Capra, Giuseppina ^{[8
]}

Casuccio, Alessandra ^{[9
]}

De Luca, Erik ^{[2
]}

Bertola, Emily ^{[3
]}

Gazzetta, Silvia ^{[1
]}

Driul, Lorenza ^{[10
]}

Isidori, Andrea ^{[7
]}

Ferro, Patrizia ^{[9
]}

Piazza, Nicolo ^{[9
]}

Immordino, Palmira ^{[9
]}

Fasciana, Teresa ^{[8
]}

Restivo, Vincenzo ^{[11
]}

机构：

[1] Univ Udine, Dipartimento Area Med, Udine, Italy

[2] Azienda Sanit Univ Friuli Cent, SOC Accreditamento Qual & Rischio Clin, Udine, Italy

[3] Azienda Sanit Univ Friuli Cent, SOC Igiene & Santa Pubbl, Dipartimento Prevenz, I-33100 Udine, Italy

[4] IRCSS Burlo Garofolo, Diagnost Avanzata Microbiol Traslaz, Via Istria 65-1, IT-34137 Trieste, Italy

[5] Univ Trieste, Dipartimento Univ Clin Sci Med Chirurg & Salute, I-34129 Trieste, Italy

[6] Ist Super Sanita, Ctr Nazl Salute Globale, I-00161 Rome, Italy

[7] Univ Sapienza Roma, Dipartimento Med Sperimentale, I-00185 Rome, Italy

[8] Univ Palermo, Dipartimento PROMISE, Sez Microbiol, I-90127 Palermo, Italy

[9] Univ Palermo, Dipartimento PROMISE, Sez Igiene, I-90127 Palermo, Italy

[10] Azienda Sanit Univ Friuli Cent, SOC Ostetr & Ginecol, Udine, Italy

[11] Univ Kore Enna, Dipartimento Med, I-94100 Enna, Italy

来源：

VACCINES | 2025年 / 13卷 / 03期

关键词：

HPV; adolescents; prevention; public health; school; HUMAN-PAPILLOMAVIRUS; BURDEN; IMPACT;

D O I：

10.3390/vaccines13030227

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Background/Objectives: HPV is the most common sexually transmitted infectious agent worldwide and adolescents are at high risk of contracting HPV. The aim of our study was to find out how much adolescents know about the virus and its effects, and to obtain information on attitudes and behaviors regarding HPV vaccination to close these gaps. Methods: As part of the ESPRIT project, 598 lower secondary (11-14 years) and upper secondary (14-19 years) school students from three Italian regions were surveyed between December 2023 and March 2024 using a seven-question online questionnaire on awareness, knowledge, and attitudes about HPV and the HPV vaccine. Count and zero-inflation models were used to determine correlations between sexes, urban/suburban, province of residence, and school type with knowledge. Results: Lower secondary students believed that HPV causes HIV/AIDS (8.9%) or hepatitis C (3.0%) and rarely mentioned anal (21%) and oral sex (9.6%) as ways of transmission. Among upper secondary students, misconceptions were similar, with worrying rates of students stating that HPV only causes cancer in females (18%) or males (2.4%), and low rates of identifying transmission risk through anal (41%) and oral (34%) sex and genital contact (38%). The HPV vaccination rate was quite low (47% in lower secondary students, 61% in upper secondary students). In the regressions, sex, urban/suburban area, and province were the variables associated with higher levels of knowledge for lower secondary students; for upper secondary students, level of knowledge was associated with sex, urban/suburban area, school type, and province of residence. Conclusions: Awareness and knowledge of HPV and the HPV vaccine are low among Italian students in this study and reported vaccination coverage is below the national target. Coordinated efforts at the national level are needed to address this public health issue.

引用

页数：17

共 22 条

[21] Lessons Learned from Implementation of a Prospective, Observational Cohort Study to Assess Risk of Spontaneous Abortion (SA) Following Administration of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine around Conception
Chambers, Christina
Johnson, Diana
Xu, Ronghui
Rosillon, Dominique
den Bosch, Judithvan
Baril, Laurence
Taylor, Sylvia
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 140 - 141
[22] Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years
Bi, Dan
Apter, Dan
Eriksson, Tiina
Hokkanen, Mari
Zima, Julia
Damaso, Silvia
Soila, Maaria
Dubin, Gary
Lehtinen, Matti
Struyf, Frank
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (06) : 1392 - 1403

← 1 2 3 →